EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quantifying Changes on OCT in Eyes Receiving Treatment for Neovascular Age-Related Macular Degeneration

Gabriella Moraes, Robbert Struyven, Siegfried K Wagner, Timing Liu, David Chong, Abdallah Abbas, Reena Chopra, Praveen J Patel, Konstantinos Balaskas, Tiarnan D L Keenan, Pearse A Keane

Ophthalmology Science · 2024-11 · 4 (6) · 100570

DOI: 10.1016/j.xops.2024.100570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ophthalmology Science, 2024-11. Verfasst von Gabriella Moraes und 10 weiteren Autor:innen. Beteiligte Einrichtung: NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Ki…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Application of artificial intelligence (AI) to macular OCT scans to segment and quantify volumetric change in anatomical and pathological features during intravitreal treatment for neovascular age-related macular degeneration (AMD).

Design

Retrospective analysis of OCT images from the Moorfields Eye Hospital AMD Database.

Participants

A total of 2115 eyes from 1801 patients starting anti-VEGF treatment between June 1, 2012, and June 30, 2017.

Methods

The Moorfields Eye Hospital neovascular AMD database was queried for first and second eyes receiving anti-VEGF treatment and had an OCT scan at baseline and 12 months. Follow-up scans were input into the AI system and volumes of OCT variables were studied at different time points and compared with baseline volume groups. Cross-sectional comparisons between time points were conducted using Mann-Whitney U test. Main Outcome Measures: Volume outputs of the following variables were studied: intraretinal fluid, subretinal fluid, pigment epithelial detachment (PED), subretinal hyperreflective material (SHRM), hyperreflective foci, neurosensory retina, and retinal pigment epithelium.

Results

Mean volumes of analyzed features decreased significantly from baseline to both 4 and 12 months, in both first-treated and second-treated eyes. Pathological features that reflect exudation, including pure fluid components (intraretinal fluid and subretinal fluid) and those with fluid and fibrovascular tissue (PED and SHRM), displayed similar responses to treatment over 12 months. Mean PED and SHRM volumes showed less pronounced but also substantial decreases over the first 2 months, reaching a plateau postloading phase, and minimal change to 12 months. Both neurosensory retina and retinal pigment epithelium volumes showed gradual reductions over time, and were not as substantial as exudative features.

Conclusions

We report the results of a quantitative analysis of change in retinal segmented features over time, enabled by an AI segmentation system. Cross-sectional analysis at multiple time points demonstrated significant associations between baseline OCT-derived segmented features and the volume of biomarkers at follow-up. Demonstrating how certain OCT biomarkers progress with treatment and the impact of pretreatment retinal morphology on different structural volumes may provide novel insights into disease mechanisms and aid the personalization of care. Data will be made public for future studies. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Schlagwörter

Stichwörter der Autor:innen

Antivascular endothelial growth factorArtificial intelligenceMachine LearningNeovascular Age-Related Macular DegenerationOptical coherence tomography

Autor:innen und Institutionen

  • NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom.
  • Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.

Förderung

  • Medical Research Council

Zitieren

APA

Moraes, G., Struyven, R., Wagner, S. K., Liu, T., Chong, D., Abbas, A., Chopra, R., Patel, P. J., Balaskas, K., Keenan, T. D. L., & Keane, P. A. (2024). Quantifying Changes on OCT in Eyes Receiving Treatment for Neovascular Age-Related Macular Degeneration. Ophthalmology Science, 4(6), 100570. https://doi.org/10.1016/j.xops.2024.100570

Vancouver

Moraes G, Struyven R, Wagner SK, Liu T, Chong D, Abbas A, et al. Quantifying Changes on OCT in Eyes Receiving Treatment for Neovascular Age-Related Macular Degeneration. Ophthalmology Science. 2024;4(6):100570. doi:10.1016/j.xops.2024.100570

BibTeX
@article{Moraes2024,
  author = {Moraes, Gabriella and Struyven, Robbert and Wagner, Siegfried K and Liu, Timing and Chong, David and Abbas, Abdallah and Chopra, Reena and Patel, Praveen J and Balaskas, Konstantinos and Keenan, Tiarnan D L and Keane, Pearse A},
  title = {Quantifying Changes on OCT in Eyes Receiving Treatment for Neovascular Age-Related Macular Degeneration},
  journal = {Ophthalmology Science},
  year = {2024},
  volume = {4},
  number = {6},
  pages = {100570},
  doi = {10.1016/j.xops.2024.100570}
}
Kostenlos starten →